Latest News
Pharma
Medtech
Biotech
Science
Careers
Events
Advertising
Press Rooms
Login
Subscribe

Facebook Like

Nordic Life Science

Search for content, post, videos

Subscribe
My account

Business
Pharma
Medtech
Biotech
Science
Careers
Events
PR Industry
Advertising
About us
Subscribe
Login

Search for content, post, videos

Tag

Phyxius

Orion-Espoo

Orion licenses the levosimendan injection rights in the USA and Canada to Phyxius

November 15, 2013

Orion Corporation and Phyxius Pharma …

Read this next

Abera Bioscience reports toxicology study results

December 5, 2023
My Nordic Corner: Umeå

December 5, 2023
Nobel Laureate: Drew Weissman

December 5, 2023
The Nobel week has begun

December 4, 2023
EXACT-Tx announces placement of NOK 25 million share issue

December 4, 2023
Herantis Pharma announces publication of preclinical data

December 4, 2023
AstraZeneca to discontinue Phase III trials

December 4, 2023
A path out of the pandemic

December 3, 2023
Three winners announced during NLSDays

December 1, 2023
Highlights from NLSDays 2023

November 30, 2023

NLS Insight

Real World Evidence

– The time is now

Read more

Editor in Chief/Web Editor

Sales & Marketing

Product manager

Subscription and customer support

+46 8 588 941 51

Postal address:

NLS Media Group AB

PO Box 2158

103 14 Stockholm

Follow @NLifeScience

NLS Media Group AB – Postal address: Kindstugatan 1, 111 31 Stockholm. Phone: +46 8 588 941 50